Summary

The global white biotech market was valued at USD 641.68 billion in 2020, and it is projected to witness a CAGR of 15.14% during the forecast period (2021 - 2026).

The COVID-19 provided a huge stimulus to the white biotech market. Massive efforts to develop vaccines, deploy test kits, develop highly predictive antibody tests, repurpose existing anti-viral drugs, and develop new drugs are causing billions of dollars to flow toward many biotech companies.

In 2021, the biotech sector is expected to value higher than in late 2019. Pre-clinical work is expected to be robust. Clinical trials may be near the volume of a year earlier. The regulatory review of clinical trials may be more efficient.

Furthermore, major pharmaceutical market giants are actively involved in product innovation and mergers and acquisitions with small-large pharmaceutical companies to make a stronghold on the white biotech market in the future.

Thus, the global COVID-19 pandemic made a significant impact on the white biotechnology market in terms of innovation in the pharmaceutical industry, which indicates a profitable market growth of the category.

The rising consumer demand for green chemicals, majorly in developed regions, like North America and Europe, are willing to pay a higher price or a green premium for numerous renewable products, which is expected to push manufacturers to employ white biotechnology processes instead of traditional chemical manufacturing.

The rising need from various consumer industries, including automotive and consumer goods, to meet the sustainability targets is expected to fuel technology demand over the forecast period.

Industrial biotechnology or white biotechnology is one of the most promising approaches to pollution prevention, resource conservation, and cost reduction. It is often referred to as the third wave in biotechnology. The use of white biotechnology can lead to the reduction of carbon dioxide emissions by as much as 50%, energy consumption by 20%, and water consumption by 75%.

Key Market Trends

Wide Application in Market with Diverse Functionality

The growing awareness about the numerous benefits associated with the application of white biotechnology, such as eco-friendly, reduced manufacturing costs, low wastage generation, and maximum raw material consumption, boosted the demand for white biotechnology among end-users in the past couple of years. For instance, in pulp and paper production and bleaching, white biotechnology has led to the reduction of chlorine chemicals application by 10-15%. The process is more efficient, consuming 40% less energy than the traditional manufacturing process. Thus, it makes an important contribution to sustainability and optimum utilization of raw material, reducing negative impacts on the environment while gaining maximum profit from the final product.

The growing need from various high-end industries, including automotive and consumer goods, to meet the sustainability targets is boosting the demand for biofuels globally.

Asia-Pacific is the Fastest-growing Region in the White Biotech Market

China’s biotech industry has grown rapidly over the past decade, and it is dominated by medical technologies and biologics. The growth is escalated by the biotechnologically altered food ingredients in the market. Thus, players are strategically investing in local companies.

For instance, in 2021, BASF Venture Capital (BVC) invested in Bota Biosciences Ltd (Bota Bio), an industrial synthetic biotech company located in Hangzhou, China, which develops next-generation biotechnology platforms, enabling sustainable and economical production of high-value products for a broad array of industrial applications, like sweeteners, vitamins, personal care, or crop protection products.

In addition to the above-mentioned industrial applications, white biotech has paved great opportunity in Japan's functional food and beverage segment due to the increased consumer inclinational toward food and beverage with high nutritional claims. Thus, biochemicals and industrial enzymes are paving great opportunities in the country’s food and beverage domain.

In 2020, DuPont Nutrition & Biosciences (DuPont) launched Powerfresh Special and Powersoft Cake 8010 in Japan, its latest enzyme range for sweet baked goods.

Competitive Landscape

The global white biotech market is highly competitive, with a strong presence of regional and global players. The demand is mostly driven by consumer awareness on sustainability and efficient productivity. Thus, the players operating in the market are trying to position themselves according to the demographic group.

Prominent players, like Corbion, ADM, and DuPont, have been focusing on developing new and innovative products by targeting the new formulation for the market and engineering the various unexplored microorganisms in the market.

Additional Benefits:

The market estimate (ME) sheet in Excel format
3 months of analyst support

ページTOPに戻る

Table of Contents